Dupilumab
LTS12551
Approved small_molecule active
Quick answer
Dupilumab for Asthma is a Approved program (small_molecule) at Sanofi Pasteur with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Sanofi Pasteur
- Indication
- Asthma
- Phase
- Approved
- Modality
- small_molecule
- Status
- active